Physician

Molly Williams Orban, M.D.

According to 2025 Medicare claims, Molly Orban, M.D. (NPI: 1063943017) practices ophthalmology in the Wilmington, NC market, with the plurality of this provider's patient population coming from Brunswick, NC. This provider's primary affiliated billing organization is WILMINGTON EYE, P.A. (NPI: 1831280205; TIN: 561120065) and primary practice location at 28401-6610.

Orban's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 617 traditional Medicare patients, billed 6,035 HCPCS/CPT codes, and received $259,874 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,281 prescription claims across 580 beneficiaries totaling $133,953 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 40 records totaling $1,277. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $2,284 and ending at $133,953. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$130K$260K2022 Medicare payment: $92,686 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $248,608 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $259,874 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20222791,446$92,686
20235913,397$248,608
20246176,035$259,874

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$67K$134K2017 Drug cost: $2,284 (USD; Tot_Drug_Cst)2018 Drug cost: $6,017 (USD; Tot_Drug_Cst)2019 Drug cost: $101,921 (USD; Tot_Drug_Cst)2020 Drug cost: $12,572 (USD; Tot_Drug_Cst)2021 Drug cost: $16,841 (USD; Tot_Drug_Cst)2022 Drug cost: $10,717 (USD; Tot_Drug_Cst)2023 Drug cost: $78,609 (USD; Tot_Drug_Cst)2024 Drug cost: $133,953 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20172467$2,284
20184484$6,017
201959176$101,921
202084251$12,572
2021131357$16,841
2022323446$10,717
2023486994$78,609
20245801,281$133,953

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more162162$108
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more303324$73
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more145179$67
92081Exam of visual field with limited testing143146$21
92285Photography of content of eyes449491$16

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine392,535$50,818
MieboPerfluorohexyloctane/Pf421,561$38,631
CyclosporineCyclosporine11990$10,532
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha6908,055$7,471
Doxycycline HyclateDoxycycline Hyclate1062,948$2,410

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.40$1,277BIOTISSUE HOLDINGS INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Molly Williams Orban, M.D.?

Tedicare shows public-source Medicare data for Molly Williams Orban, M.D. (NPI 1063943017), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Molly Williams Orban, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Molly Williams Orban, M.D.?

Molly Williams Orban, M.D. is linked to WILMINGTON EYE, P.A. (billing NPI 1831280205) in the available physician profile data.

Does Molly Williams Orban, M.D. have Open Payments data?

Molly Williams Orban, M.D. has 40 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.